Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia. Dulyayangkul P, Charoenlap N, Srijaruskul K, Mongkolsuk S, Vattanaviboon P. J Antimicrob Chemother. 2016 Oct;71(10):2990-1. doi: 10.1093/jac/dkw233. No abstract

28 Dec 2016
0

Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia.
Dulyayangkul P, Charoenlap N, Srijaruskul K, Mongkolsuk S, Vattanaviboon P.
J Antimicrob Chemother. 2016 Oct;71(10):2990-1. doi: 10.1093/jac/dkw233. No abstract

Tags

Share this

Related Posts

Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., . . . Ruchirawat, M. (2018). Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines. Oncol Lett, 16(2), 1529-1538. doi:10.3892/ol.2018.8807

Recent Posts